Kazuaki Okamura Yuichi Fukuda Hiroshi Soda Daiki Ogawara Keisuke Iwasaki Shinichiro Fuchi Takayuki Suyama Masataka Yoshida Tatsuhiko Harada Minoru Fukuda Hiroshi Mukae
10.1111/1759-7714.12557
Thorac Cancer
2018 Jan;9(1):193-196.
immunotherapy programmed death-1 regulatory t cells
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/29131510/
Antibodies, Monoclonal / therapeutic use Immunotherapy / methods Lung Neoplasms / drug therapy T-Lymphocytes, Regulatory / immunology
Antibodies, Monoclonal / therapeutic use Immunotherapy / methods Lung Neoplasms / drug therapy T-Lymphocytes, Regulatory / immunology Case Reports Aged Antibodies, Monoclonal / pharmacology Humans Lung Neoplasms / pathology Male Nivolumab Antibodies, Monoclonal Nivolumab
PMC5754285
29131510
Pulmonary pleomorphic carcinoma with few PD-1-positive immune cells and regulatory T cells that showed a complete response to nivolumab
2018